Fmr LLC Fate Therapeutics Inc Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Fmr LLC holds 34,063 shares of FATE stock, worth $52,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,063

Previous 57,897 41.17%

Holding current value

$52,457

Previous $45,000 15.56%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.68 - $1.67 $16,207 - $39,802	-23,834 Reduced 41.17%	34,063 $38,000
Q1 2025 May 12, 2025	SELL	$0.79 - $1.87 $236,262 - $559,255	-299,067 Reduced 83.78%	57,897 $45,000
Q4 2024 Feb 13, 2025	BUY	$1.61 - $3.35 $207,662 - $432,093	128,983 Added 56.58%	356,964 $588,000
Q3 2024 Nov 13, 2024	BUY	$3.12 - $5.57 $146,303 - $261,188	46,892 Added 25.89%	227,981 $797,000
Q2 2024 Aug 13, 2024	SELL	$3.26 - $7.08 $243,055 - $527,863	-74,557 Reduced 29.16%	181,089 $593,000
Q1 2024 May 13, 2024	SELL	$3.54 - $8.35 $125,762 - $296,642	-35,526 Reduced 12.2%	255,646 $1.88 Million
Q4 2023 Feb 13, 2024	SELL	$1.65 - $3.94 $27,155 - $64,844	-16,458 Reduced 5.35%	291,172 $1.09 Million
Q3 2023 Nov 13, 2023	SELL	$2.02 - $5.04 $461,032 - $1.15 Million	-228,234 Reduced 42.59%	307,630 $652,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $462,971 - $640,963	-97,263 Reduced 15.36%	535,864 $2.55 Million
Q1 2023 May 11, 2023	BUY	$4.24 - $11.12 $16,379 - $42,956	3,863 Added 0.61%	633,127 $3.61 Million
Q4 2022 Feb 13, 2023	SELL	$9.86 - $23.83 $8.21 Million - $19.8 Million	-832,801 Reduced 56.96%	629,264 $6.35 Million
Q3 2022 Nov 10, 2022	BUY	$21.04 - $36.06 $1.01 Million - $1.74 Million	48,206 Added 3.41%	1,462,065 $32.8 Million
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $3.59 Million - $8.56 Million	-201,857 Reduced 12.49%	1,413,859 $35 Million
Q1 2022 May 13, 2022	SELL	$29.67 - $60.28 $4.8 Million - $9.74 Million	-161,613 Reduced 9.09%	1,615,716 $62.6 Million
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $22.6 Million - $30.4 Million	-472,121 Reduced 20.99%	1,777,329 $104 Million
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $249 Million - $402 Million	-4,201,477 Reduced 65.13%	2,249,450 $133 Million
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $434 Million - $597 Million	6,450,927 New	6,450,927 $560 Million

Others Institutions Holding FATE

# of Institutions

150

Shares Held

83.3M

Call Options Held

179K

Put Options Held

13.4K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $149M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account